Process View
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving polysaccharides.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of polysaccharide metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.987 | Human | |
| INSR | insulin receptor | 0.926 | ||
| NUMB | numb homolog (Drosophila) | 0.701 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.655 | Rat | |
| IGF1R | insulin-like growth factor 1 receptor | 0.572 | Human | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.550 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.404 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.323 | ||
| IRS1 | insulin receptor substrate 1 | 0.309 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.308 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.305 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.254 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.219 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.185 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.159 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.156 | ||
| HIP1 | huntingtin interacting protein 1 | 0.151 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.123 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.123 | ||
| IRS2 | insulin receptor substrate 2 | 0.121 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.103 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.090 | ||
| VEGFA | vascular endothelial growth factor A | 0.084 | Human | |
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.074 | ||
| PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.074 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.069 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.068 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.066 | Human | |
| APP | amyloid beta (A4) precursor protein | 0.064 | ||
| NRP1 | neuropilin 1 | 0.062 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.062 | ||
| ENG | endoglin | 0.057 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.054 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.054 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.052 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.051 | ||
| PRKCZ | protein kinase C, zeta | 0.048 | Human | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.043 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.042 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.039 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.033 | ||
| PGF | placental growth factor | 0.032 | Human | |
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.031 | ||
| HR | hairless homolog (mouse) | 0.030 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.029 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.029 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.025 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.024 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.024 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.024 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.024 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.023 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.023 | ||
| PRKCA | protein kinase C, alpha | 0.023 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.023 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.023 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.021 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.020 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.020 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.020 | ||
| EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.019 | ||
| CAPRIN2 | caprin family member 2 | 0.019 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.018 | ||
| CCND1 | cyclin D1 | 0.018 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.017 | ||
| CXXC5 | CXXC finger protein 5 | 0.017 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.017 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.017 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.016 | ||
| OSBP | oxysterol binding protein | 0.016 | ||
| THBS1 | thrombospondin 1 | 0.016 | ||
| STC1 | stanniocalcin 1 | 0.016 | ||
| PRKCB | protein kinase C, beta | 0.016 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.015 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.015 | ||
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.015 | Human | |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | Human | |
| CREB1 | cAMP responsive element binding protein 1 | 0.014 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.014 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.014 | ||
| PDGFC | platelet derived growth factor C | 0.014 | ||
| CDCP1 | CUB domain containing protein 1 | 0.013 | ||
| PPP1R3F | protein phosphatase 1, regulatory (inhibitor) subunit 3F | 0.012 | ||
| EGFR | epidermal growth factor receptor | 0.012 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.012 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.012 | ||
| LDLR | low density lipoprotein receptor | 0.012 | ||
| HTT | huntingtin | 0.012 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.011 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.011 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.011 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.011 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.011 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.010 | Human | |
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.010 | ||
| FAM117B | family with sequence similarity 117, member B | 0.010 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.010 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.010 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.010 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.010 |